MAIN TOPICS
Hypertension and Risk of Stroke
Dyslipidemia and Risk of Stroke
HDL and Risk of Stroke
Statins and Stroke Risk Reduction
ACE, ARBS and CCBS in Stroke Prevention
Emerging Biomarkers of Stroke
PPAR Alpha Agonists and ACAT-Inhibitors and Stroke
Carotid Atherosclerosis (IMT) as a Surrogate Endpoint for Therapeutic Intervention
Stroke Prevention and Vascular Dementia
Endocanabinoid Receptor Blocker
Diabetic, Metabolic Syndrome and Stroke Prevention
Therapeutic Intervention to Reduce Stroke
Risk Factor and Vascular Cognitive Impairment
|
 |
